Imprint
Imprint according to the following German regulations: § 6 TDG, § 10 MDStV
Publisher
Helmholtz-Zentrum für Infektionsforschung GmbH
Inhoffenstraße 7 | 38124 Braunschweig | Germany
Phone: +49 531 6181-0 | Fax: +49 531 6181-2655
Internet: www.helmholtz-hzi.de
Legal Form
The Helmholtz Centre for Infection Research is a Gesellschaft mit beschränkter Haftung (GmbH), which is similar to a limited liability company.
Commercial Register Braunschweig, Germany
Registration Number: HRB 477
Persons authorised to represent
Prof Dr Dirk Heinz, Executive director
Silke Tannapfel, Administrative director
(address like above)
Supervisory Board
MinDir'in Prof. Dr. Veronika von Messling (Chair),
Bundesministerium für Bildung und Forschung
Ministerialdirigent Rüdiger Eichel (Deputy Chairman),
Niedersächsisches Ministerium für Wissenschaft und Kultur
MinR'in Dr. Antina Ziegelmann,
Bundesministerium für Gesundheit
Dr. Annette Groh,
Saarland - Staatskanzlei
Ministerialrat Dr. Robert Geiger,
Bayrisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie
Prof. Dr. med. Michael Manns,
Medizinische Hochschule Hannover
Prof. Dr. Christoph Dehio,
Universität Basel
Prof. Dr. med. Simone Scheithauer,
Georg-August-Universität Göttingen
Dr. Gerd Maass,
Roche Diagnostics GmbH
Prof. Dr. Luka Cicin-Sain,
Helmholtz-Zentrum für Infektionsforschung
Dr. Stefanie Castell,
Helmholtz-Zentrum für Infektionsforschung
Prof. Dr. Percy A. Knolle,
Technische Universität München
Prof. Dr. Susanne Herold,
Universtätsklinikum Gießen und Marburg
Value Added Tax Identification Number (according to § 27 a UStG)
DE 114815244
Responsible for site content
Helmholtz-Zentrum für Infektionsforschung GmbH
Susanne Thiele
Inhoffenstraße 7 | 38124 Braunschweig | Germany
Phone: +49 531 6181-0 | Fax: +49 531 6181-1499
This applies to
https://twitter.com/Helmholtz_HIRI
Picture Credits
© Photos in the slider element on the welcome page
Doranth post architekten
Adobe Stock/Naeblys
Corporate Governance
The Helmholtz Centre for Infection Research GmbH submits to the "Public Corporate Governance Code (PCGC)" of the federal government according to the memorandum of association. The Code recommends that the management and the supervisory board reports on the Company's corporate governance (Corporate Governance Report) on an annual basis.
The report refers to the PCGK as constituted on 30th of June 2009. Management and Supervisory Board declare that the recommendations of the Code are being complied essentially and will, deviations are explained in the respective report.
The Management Board and Supervisory Board declare that the Federal Public Corporate Governance Code as amended on 30 June 2009 has been complied with with reasonable deviations from the prescribed recommendations.
PCGK-Report 2011
PCGK-Report 2012
PCGK-Report 2013
PCGK-Report 2014
PCGK-Report 2015
PCGK-Report 2016
PCGK-Report 2017
Disclaimer
The Helmholtz Centre for Infection Research does not take any responsibility for damages that occur in connection with any use of this website. The content of this website gets reviewed and updated on a regular basis if possible, a guarantee for correctness of any content can't be given in any case though.
Information
We do not take any liability for any content of any external sites we link to. The content of external sites belongs to the sphere of responsibility of it's respective publishers.
The data in this imprint is exclusively intended for getting in contact with us regarding content and legal issues. Any use of this data for advertisement is strictly prohibited.
Implementation Partner
Conception, design and technical implementation realised by:
Bitmotion GmbH
KALA YOUR LIFE® KYL Digitalagentur GmbH